MUC1 and cancer: MUC1 promotes cancer cell invasion and epithelial‐to‐mesenchymal transition (EMT) through its interaction with beta‐catenin,49 both of which are reduced upon treatment with SAM + 5AzadC (Figure 4A; Appendix S1: Figure S2).